$PBIO To date, we have installed over 300 PCT systems in approximately 200 sites worldwide. There are over 120 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. Customers also use our products in other areas, such as bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.
Take a look at the profile here: privateequitymarkets.us/pressure-biosciences-inc-otcqbpbio
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!